Isolation, structural characterization and pharmacological activity of dog neuromedin U

Finbarr O'Harte, Charles Bockman, Peter W. Abel, J. Michael Conlon

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The neuromedin U-like immunoreactivity in an extract of dog small intestine was resolved by reversed-phase HPLC into two molecular forms. The primary structure of the larger form (NMU-25) was established as: Phe-Arg-Leu-Asp-Glu-Glu-Phe-Gln-Gly-Pro10-Ile-Ala-Ser-Gln-Val-Arg-Arg-Gln-Phe-Leu20-Phe-Arg-Pro-Arg-Asn-NH2. This sequence shows five substitutions relative to pig neuromedin U-25. The primary structure of the second peptide (NMU-8) was established as: pGlu-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2. The sequence contains the substitution pGlu for Tyr1 compared with pig neuromedin U-8. The potency of synthetic dog NMU-8 in contracting smooth muscle from the rat uterus (EC50 10±2 nM; mean ± S.E., n=6) was not significantly different from the corresponding potency of pig NMU-8 (EC50 16±5 nM) but the maximum response produced by the dog peptide was greater (58%; p

Original languageEnglish
Pages (from-to)11-15
Number of pages5
JournalPeptides
Volume12
Issue number1
DOIs
StatePublished - 1991

Fingerprint

neuromedin U 8
Pharmacology
Dogs
Swine
Substitution reactions
Peptides
Small Intestine
Uterus
Smooth Muscle
Muscle
Rats
High Pressure Liquid Chromatography
neuromedin U

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Isolation, structural characterization and pharmacological activity of dog neuromedin U. / O'Harte, Finbarr; Bockman, Charles; Abel, Peter W.; Conlon, J. Michael.

In: Peptides, Vol. 12, No. 1, 1991, p. 11-15.

Research output: Contribution to journalArticle

@article{069cdfec604d4197a7c5c46e996be30a,
title = "Isolation, structural characterization and pharmacological activity of dog neuromedin U",
abstract = "The neuromedin U-like immunoreactivity in an extract of dog small intestine was resolved by reversed-phase HPLC into two molecular forms. The primary structure of the larger form (NMU-25) was established as: Phe-Arg-Leu-Asp-Glu-Glu-Phe-Gln-Gly-Pro10-Ile-Ala-Ser-Gln-Val-Arg-Arg-Gln-Phe-Leu20-Phe-Arg-Pro-Arg-Asn-NH2. This sequence shows five substitutions relative to pig neuromedin U-25. The primary structure of the second peptide (NMU-8) was established as: pGlu-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2. The sequence contains the substitution pGlu for Tyr1 compared with pig neuromedin U-8. The potency of synthetic dog NMU-8 in contracting smooth muscle from the rat uterus (EC50 10±2 nM; mean ± S.E., n=6) was not significantly different from the corresponding potency of pig NMU-8 (EC50 16±5 nM) but the maximum response produced by the dog peptide was greater (58{\%}; p",
author = "Finbarr O'Harte and Charles Bockman and Abel, {Peter W.} and Conlon, {J. Michael}",
year = "1991",
doi = "10.1016/0196-9781(91)90159-M",
language = "English",
volume = "12",
pages = "11--15",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Isolation, structural characterization and pharmacological activity of dog neuromedin U

AU - O'Harte, Finbarr

AU - Bockman, Charles

AU - Abel, Peter W.

AU - Conlon, J. Michael

PY - 1991

Y1 - 1991

N2 - The neuromedin U-like immunoreactivity in an extract of dog small intestine was resolved by reversed-phase HPLC into two molecular forms. The primary structure of the larger form (NMU-25) was established as: Phe-Arg-Leu-Asp-Glu-Glu-Phe-Gln-Gly-Pro10-Ile-Ala-Ser-Gln-Val-Arg-Arg-Gln-Phe-Leu20-Phe-Arg-Pro-Arg-Asn-NH2. This sequence shows five substitutions relative to pig neuromedin U-25. The primary structure of the second peptide (NMU-8) was established as: pGlu-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2. The sequence contains the substitution pGlu for Tyr1 compared with pig neuromedin U-8. The potency of synthetic dog NMU-8 in contracting smooth muscle from the rat uterus (EC50 10±2 nM; mean ± S.E., n=6) was not significantly different from the corresponding potency of pig NMU-8 (EC50 16±5 nM) but the maximum response produced by the dog peptide was greater (58%; p

AB - The neuromedin U-like immunoreactivity in an extract of dog small intestine was resolved by reversed-phase HPLC into two molecular forms. The primary structure of the larger form (NMU-25) was established as: Phe-Arg-Leu-Asp-Glu-Glu-Phe-Gln-Gly-Pro10-Ile-Ala-Ser-Gln-Val-Arg-Arg-Gln-Phe-Leu20-Phe-Arg-Pro-Arg-Asn-NH2. This sequence shows five substitutions relative to pig neuromedin U-25. The primary structure of the second peptide (NMU-8) was established as: pGlu-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2. The sequence contains the substitution pGlu for Tyr1 compared with pig neuromedin U-8. The potency of synthetic dog NMU-8 in contracting smooth muscle from the rat uterus (EC50 10±2 nM; mean ± S.E., n=6) was not significantly different from the corresponding potency of pig NMU-8 (EC50 16±5 nM) but the maximum response produced by the dog peptide was greater (58%; p

UR - http://www.scopus.com/inward/record.url?scp=0026023547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026023547&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(91)90159-M

DO - 10.1016/0196-9781(91)90159-M

M3 - Article

C2 - 2052487

AN - SCOPUS:0026023547

VL - 12

SP - 11

EP - 15

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 1

ER -